Development of Monoclonal Antibodies for the Study of Mycobacterium tuberculosis (Mtb) in the Guinea Pig
Award amount
$600,000Program and phase
SBIR · Phase IAward year
2023Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- GLYCOSCIENTIFIC, L.L.C.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- EUVNNWGFCA87
- Solicitation number
- PHS-2023-1
- Topic code
- 118
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Recognition of O-GlcNAc Modified Proteins Using Site-Specific Antibodies
- Development of Isotopically Labeled Glycoproteins for use as Internal Standards
- Isotopically Labeled Heparan Sulfate Glycosaminoglycan Disaccharides for use as Internal Standards
- Development of Site-specific Arg-GlcNAc Antibodies
- Creating Antibodies to Enable the Study of Mycobacterium Tuberculosis Infections in Guinea Pigs
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Affinity Reagents for the Immune System of Golden Hamster (for SARS-CoV-2 induced long-COVID disease)
- Epitope-directed monoclonal antibody production for mosquito immune cells (for malaria)
- Reagents for Immunologic Analysis of Under-represented Mammalian Models
- EAP-Derived Monoclonal Antibodies for Phenotyping Immune Cells of Animal Model of Disease
Research funding history
12 SBIR/STTR records share this UEI (2011–2023). Reported award amounts total $5,523,413. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services